Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study
暂无分享,去创建一个
S. A. Wijtenburg | L. Rowland | R. Edden | L. Hong | R. Edden | P. Barker | P B Barker | S. Pradhan | Stephanie A. Korenic | L M Rowland | S Pradhan | S Korenic | S A Wijtenburg | L E Hong | R A Edden | S. Korenic | Laura M. Rowland | P. B. Barker | R. Edden
[1] T. Crawford,et al. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. , 2003, AJNR. American journal of neuroradiology.
[2] P. Moreira. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin. , 2012, Journal of Alzheimer's disease : JAD.
[3] R. Gruetter,et al. N-Acetylcysteine Normalizes Neurochemical Changes in the Glutathione-Deficient Schizophrenia Mouse Model During Development , 2012, Biological Psychiatry.
[4] R. Paz,et al. Long-Term Treatment of Rats with Haloperidol: Lack of an Effect on Brain N-Acetyl Aspartate Levels , 2006, Neuropsychopharmacology.
[5] L. Szweda,et al. α-Ketoglutarate dehydrogenase: A mitochondrial redox sensor , 2011, Free radical research.
[6] M. Krams,et al. Impaired mitochondrial function in psychiatric disorders , 2012, Nature Reviews Neuroscience.
[7] Mark Slifstein,et al. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. , 2012, Archives of general psychiatry.
[8] R. Gruetter,et al. Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis. , 2016, Schizophrenia bulletin.
[9] P. Renshaw,et al. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research , 2005, Molecular Psychiatry.
[10] A. Lahti,et al. Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia , 2015, Schizophrenia Research.
[11] A. Kulak. N-ACETYLCYSTEINE NORMALIZES NEUROCHEMICAL CHANGES IN THE GLUTATHIONE-DEFICIENT SCHIZOPHRENIA MOUSE MODEL DURING DEVELOPMENT , 2012, Schizophrenia Research.
[12] J. Finsterer,et al. Cognitive dysfunction in mitochondrial disorders , 2012, Acta neurologica Scandinavica.
[13] J. Gold,et al. Next-generation negative symptom assessment for clinical trials: Validation of the Brief Negative Symptom Scale , 2012, Schizophrenia Research.
[14] G. Sutherland,et al. Lactate Storm Marks Cerebral Metabolism following Brain Trauma* , 2014, The Journal of Biological Chemistry.
[15] J. Knoefel,et al. The neuropathology and cerebrovascular mechanisms of dementia , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] R. Gruetter,et al. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.
[17] Roger J. Ordidge,et al. THE CORRECTION OF TRANSIENT B0 FIELD SHIFTS FOLLOWING THE APPLICATION OF PULSED GRADIENTS BY PHASE CORRECTION IN THE TIME DOMAIN , 1986 .
[18] B. Cohen,et al. In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy. , 2014, JAMA psychiatry.
[19] S. A. Wijtenburg,et al. Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia. , 2016, JAMA psychiatry.
[20] Michael F. Green,et al. Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. , 2011, The American journal of psychiatry.
[21] R. Caivano,et al. 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature , 2013, The International journal of neuroscience.
[22] Ravi S. Menon,et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.
[23] Roland Kreis,et al. The trouble with quality filtering based on relative Cramér‐Rao lower bounds , 2016, Magnetic resonance in medicine.
[24] A. Graff-Guerrero,et al. Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study. , 2013, JAMA psychiatry.
[25] D. Ben-shachar,et al. Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia , 2016, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[26] A. Lahti,et al. Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. , 2013, JAMA psychiatry.
[27] S. Woods,et al. Chlorpromazine equivalent doses for the newer atypical antipsychotics. , 2003, The Journal of clinical psychiatry.
[28] Peter B Barker,et al. Comparison of single voxel brain MRS AT 3T and 7T using 32-channel head coils. , 2015, Magnetic resonance imaging.
[29] S. Mathew,et al. Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder , 2010, NMR in biomedicine.
[30] R. Conley,et al. Elevated Cerebrospinal Fluid Lactate Concentrations in Patients with Bipolar Disorder and Schizophrenia: Implications for the Mitochondrial Dysfunction Hypothesis , 2009, Biological Psychiatry.
[31] Michael Schär,et al. Optimized detection of lactate at high fields using inner volume saturation , 2006, Magnetic resonance in medicine.
[32] A. Graff-Guerrero,et al. Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis , 2011, Neuropsychopharmacology.
[33] Rolf Gruetter,et al. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T , 2009, Magnetic resonance in medicine.
[34] Linda Chang,et al. Brain Metabolite Abnormalities in the White Matter of Elderly Schizophrenic Subjects: Implication for Glial Dysfunction , 2007, Biological Psychiatry.
[35] R. Murray,et al. Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function , 2014, Biological Psychiatry.
[36] R. Liberman,et al. Consistency of Brief Psychiatric Rating Scale Factor Structure across a Broad Spectrum of Schizophrenia Patients , 2007, Psychopathology.
[37] F. Turkheimer,et al. Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive. , 2016, Schizophrenia bulletin.
[38] Mahaveer Degaonkar,et al. Metabolites in ventricular cerebrospinal fluid detected by proton magnetic resonance spectroscopic imaging , 2004, Journal of magnetic resonance imaging : JMRI.
[39] J. Dennis,et al. Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies , 2016, Aging and disease.
[40] S. Provencher. Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.
[41] K. Uğurbil,et al. In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T , 2009, Magnetic resonance in medicine.
[42] Rolf Gruetter,et al. Are glutamate and lactate increases ubiquitous to physiological activation? A 1H functional MR spectroscopy study during motor activation in human brain at 7Tesla , 2014, NeuroImage.
[43] D. Klomp,et al. Detection of lactate in the striatum without contamination of macromolecules by J‐difference editing MRS at 7 T , 2015, NMR in biomedicine.
[44] J. Kleinman,et al. Increased lactate levels and reduced pH in postmortem brains of schizophrenics: Medication confounds , 2008, Journal of Neuroscience Methods.
[45] Michael F. Green,et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria , 2004, Biological Psychiatry.
[46] N. Logothetis,et al. Dynamics of lactate concentration and blood oxygen level‐dependent effect in the human visual cortex during repeated identical stimuli , 2007, Journal of neuroscience research.
[47] Jun-Feng Wang,et al. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. , 2009, Bipolar disorders.
[48] J. Lauriello,et al. 1H-MRS at 4 Tesla in minimally treated early schizophrenia , 2010, Molecular Psychiatry.
[49] M. Beal. Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.
[50] α-Ketoglutarate Dehydrogenase: A Mitochondrial Redox Sensor , 2010 .
[51] Kevin Murphy,et al. Temporal dynamics of lactate concentration in the human brain during acute inspiratory hypoxia , 2013, Journal of magnetic resonance imaging : JMRI.
[52] Clifford Qualls,et al. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T. , 2014, JAMA psychiatry.
[53] Ravi S. Menon,et al. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. , 2003, The American journal of psychiatry.
[54] R. Yolken,et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress , 2004, Molecular Psychiatry.